Junxia Wang. Development of Multiplex Sensitive Anti-Drug Antibody Assays for CRISPR/Cas9 Gene Therapies, September 27, 2017.

Mar

20

Editas Medicine Announces Chief Financial Officer Transition

Mar

5

Editas Medicine Announces Fourth Quarter and Full Year 2024 Results and Business Updates

Feb

24

Editas Medicine to Announce Fourth Quarter/Full Year 2024 Financial Results and to Participate in Investor Conferences in March